Rayence Co

Rayence Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of Rayence Co (228850.KQ) as of Nov 7, 2026 is 28.88. In the previous year, Days Payable Outstanding (DPO) was 22.86 — a change of 26.31% (higher).

Days Payable Outstanding

28.88

YoY

26.31%

Last updated:

Days Payable Outstanding (DPO) of Rayence Co is 2025 28.88 . Days Payable Outstanding (DPO) of Rayence Co was 2024 22.86 . It decreases by 26.31% higher compared to the previous year.

The Rayence Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
30.49 KRW
Jan 1, 2019
32.23 KRW
Jan 1, 2020
31.25 KRW
Jan 1, 2021
35.16 KRW
Jan 1, 2022
19.38 KRW
Jan 1, 2023
24.27 KRW
Jan 1, 2024
22.86 KRW
Jan 1, 2025
28.88 KRW
The Rayence Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
28.88+26.31%
22.86-5.80%
24.27+25.28%
19.38-44.89%
35.16+12.52%
31.25-3.04%
32.23+5.69%
30.49-15.72%
36.18-27.87%
50.15+5.85%
47.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Days Payable Outstanding (DPO) of Rayence Co is 28.88 in 2025.

Days Payable Outstanding (DPO) of Rayence Co changed from 22.86 to 28.88, representing a 26.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Rayence Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Rayence Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Rayence Co

All Key Metrics — Rayence Co